Literature DB >> 18988292

Changes in the presentation of nodular and superficial spreading melanomas over 35 years.

Melanie A Warycha1, Paul J Christos, Madhu Mazumdar, Farbod Darvishian, Richard L Shapiro, Russell S Berman, Anna C Pavlick, Alfred W Kopf, David Polsky, Iman Osman.   

Abstract

BACKGROUND: Nodular melanoma (NM) may be biologically aggressive compared with the more common superficial spreading melanoma (SSM), with recent data suggesting underlying genetic differences between these 2 subtypes. To better define the clinical behavior of NMs, the authors compared their clinical and histopathologic features to those of SSMs at their institution, a tertiary referral center, over 3 decades.
METHODS: A total of 1,684 patients diagnosed with 1,734 melanomas were prospectively enrolled. Of these, 1,143 patients (69% SSM, 11% NM, 20% other) were diagnosed between 1972 and 1982; 541 patients (54% SSM, 23% NM, 23% other) were diagnosed between 2002 and the present. Differences between the features of NM and SSM within each time period as well as changes over time were analyzed.
RESULTS: The authors found that SSMs are now diagnosed as thinner lesions (P < .0001) with a low incidence of histologic ulceration (P < .0001), whereas there was no significant change in the median tumor thickness or ulceration status of NMs over time (P = .10, P = .30, respectively). The median age at diagnosis of NM, however, did significantly increase over time (51 years to 63 years, P < .01). The median duration of NMs was reported to be only 5 months compared with 9 months in SSM patients.
CONCLUSIONS: The authors' data suggest that improvements have been made in the early detection of SSM but not NM. Modifications of current screening practices, including increased surveillance of high-risk patients with an emphasis on the "E" for "evolution" criterion of the ABCDE acronym used for early detection of melanoma, are thus warranted.

Entities:  

Mesh:

Year:  2008        PMID: 18988292      PMCID: PMC3624077          DOI: 10.1002/cncr.23955

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  33 in total

1.  Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program.

Authors:  Anne M Lachiewicz; Marianne Berwick; Charles L Wiggins; Nancy E Thomas
Journal:  J Invest Dermatol       Date:  2007-08-23       Impact factor: 8.551

2.  Detection of nodular and superficial spreading melanoma with tumour thickness < or = 2.0 mm--an interview study.

Authors:  M Bergenmar; J Hansson; Y Brandberg
Journal:  Eur J Cancer Prev       Date:  2002-02       Impact factor: 2.497

Review 3.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Authors:  C M Balch; A C Buzaid; S J Soong; M B Atkins; N Cascinelli; D G Coit; I D Fleming; J E Gershenwald; A Houghton; J M Kirkwood; K M McMasters; M F Mihm; D L Morton; D S Reintgen; M I Ross; A Sober; J A Thompson; J F Thompson
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

4.  Recent trends in cutaneous melanoma incidence among whites in the United States.

Authors:  A Jemal; S S Devesa; P Hartge; M A Tucker
Journal:  J Natl Cancer Inst       Date:  2001-05-02       Impact factor: 13.506

5.  Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.

Authors:  Alexander J Chamberlain; Lin Fritschi; Graham G Giles; John P Dowling; John W Kelly
Journal:  Arch Dermatol       Date:  2002-05

6.  Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection.

Authors:  Alexander J Chamberlain; Lin Fritschi; John W Kelly
Journal:  J Am Acad Dermatol       Date:  2003-05       Impact factor: 11.527

7.  Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.

Authors:  Bruce Ng; Jan Zakrzewski; Melanie Warycha; Paul J Christos; Dean F Bajorin; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Anthony Montgomery; Leonard Liebes; Peter C Brooks; Iman Osman
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005.

Authors:  Matthew S Goldberg; John T Doucette; Henry W Lim; James Spencer; John A Carucci; Darrell S Rigel
Journal:  J Am Acad Dermatol       Date:  2007-05-09       Impact factor: 11.527

9.  Nodular melanoma. No longer as simple as ABC.

Authors:  John W Kelly; Alexander J Chamberlain; Margaret P Staples; Brian McAvoy
Journal:  Aust Fam Physician       Date:  2003-09

10.  Improving melanoma classification by integrating genetic and morphologic features.

Authors:  Amaya Viros; Jane Fridlyand; Juergen Bauer; Konstantin Lasithiotakis; Claus Garbe; Daniel Pinkel; Boris C Bastian
Journal:  PLoS Med       Date:  2008-06-03       Impact factor: 11.069

View more
  17 in total

1.  Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.

Authors:  Amy E Rose; Laura Poliseno; Jinhua Wang; Michael Clark; Alexander Pearlman; Guimin Wang; Eleazar C Vega Y Saenz de Miera; Ratna Medicherla; Paul J Christos; Richard Shapiro; Anna Pavlick; Farbod Darvishian; Jiri Zavadil; David Polsky; Eva Hernando; Harry Ostrer; Iman Osman
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

Review 2.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Authors:  Holly S Greenwald; Erica B Friedman; Iman Osman
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

3.  Histology-specific microRNA alterations in melanoma.

Authors:  Laura Poliseno; Adele Haimovic; Miguel F Segura; Douglas Hanniford; Paul J Christos; Farbod Darvishian; Jinhua Wang; Richard L Shapiro; Anna C Pavlick; Russell S Berman; Eva Hernando; Jiri Zavadil; Iman Osman
Journal:  J Invest Dermatol       Date:  2012-05-03       Impact factor: 8.551

4.  Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.

Authors:  Michael Lattanzi; Yesung Lee; Danny Simpson; Una Moran; Farbod Darvishian; Randie H Kim; Eva Hernando; David Polsky; Doug Hanniford; Richard Shapiro; Russell Berman; Anna C Pavlick; Melissa A Wilson; Tomas Kirchhoff; Jeffrey S Weber; Judy Zhong; Iman Osman
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

5.  RSK1 activation promotes invasion in nodular melanoma.

Authors:  Amel Salhi; Joshua A Farhadian; Keith M Giles; Eleazar Vega-Saenz de Miera; Ines P Silva; Caitlin Bourque; Karen Yeh; Sagar Chhangawala; Jinhua Wang; Fei Ye; David Y Zhang; Eva Hernando-Monge; Yariv Houvras; Iman Osman
Journal:  Am J Pathol       Date:  2015-01-08       Impact factor: 4.307

6.  Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research.

Authors:  Lindsay G Wich; Heather K Hamilton; Richard L Shapiro; Anna Pavlick; Russell S Berman; David Polsky; Judith D Goldberg; Eva Hernando; Prashiela Manga; Michelle Krogsgaard; Hideko Kamino; Farbod Darvishian; Peng Lee; Seth J Orlow; Harry Ostrer; Nina Bhardwaj; Iman Osman
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

7.  Increased shedding of HU177 correlates with worse prognosis in primary melanoma.

Authors:  Heather K Hamilton; Amy E Rose; Paul J Christos; Richard L Shapiro; Russell S Berman; Madhu Mazumdar; Michelle W Ma; Daniel Krich; Leonard Liebes; Peter C Brooks; Iman Osman
Journal:  J Transl Med       Date:  2010-02-23       Impact factor: 5.531

8.  KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.

Authors:  José A Campillo; Isabel Legaz; M Rocío López-Álvarez; José Miguel Bolarín; Beatriz Las Heras; Manuel Muro; Alfredo Minguela; María R Moya-Quiles; Rosa Blanco-García; Helios Martínez-Banaclocha; Ana M García-Alonso; M Rocío Alvarez-López; Jorge A Martínez-Escribano
Journal:  Immunogenetics       Date:  2013-01-31       Impact factor: 2.846

Review 9.  Revisiting determinants of prognosis in cutaneous melanoma.

Authors:  Sarah A Weiss; Douglas Hanniford; Eva Hernando; Iman Osman
Journal:  Cancer       Date:  2015-08-26       Impact factor: 6.860

10.  MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project.

Authors:  Saverio Caini; Sara Gandini; Francesca Botta; Elena Tagliabue; Sara Raimondi; Eduardo Nagore; Ines Zanna; Patrick Maisonneuve; Julia Newton-Bishop; David Polsky; DeAnn Lazovich; Rajiv Kumar; Peter A Kanetsky; Veronica Hoiom; Paola Ghiorzo; Maria Teresa Landi; Gloria Ribas; Chiara Menin; Alexander J Stratigos; Giuseppe Palmieri; Gabriella Guida; Jose Carlos García-Borrón; Hongmei Nan; Julian Little; Francesco Sera; Susana Puig; Maria Concetta Fargnoli
Journal:  Melanoma Res       Date:  2020-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.